URINARY PROSTACYCLIN IN NONSMOKERS LIVING WITH SMOKERS

References

• Banga, H. S., Simons, E. R., Brass, L. F., and Rittenhouse, S. E. 1986. Activation of phospholipases A and C in human platelets exposed to epinephrine: Role of glycoproteins Ilb/Illa and dual role of epinephrine. Proc. Natl. Acad. Sci. USA 3:9197–9201.
   Google Scholar
• Barrow, S. E. 1989. Cigarette smoking: Profiles of thromboxane and prostacyclin derived products in human urine. Biochim. Biophys. Acta 993(1)121–127.
   Google Scholar
• Burghuber, 0., Punzengruber, C., Sinzinger, H., Haber, P., and Silberbauer, K. 1986. Platelet sensi-tivity to prostacyclin in smokers and non-smokers. Chest 90:34–38.
   Google Scholar
• Cryer, P. E., Haymond, M. W., Santiago, J. V., and Shah, S. D. 1976. Norepinephrine and epineph-rine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl.]. Med. 295:573–537.
   PubMed Web of Science ®Google Scholar
• Davis, J., Shelton, L., Watanabe, I., and Arnold, J. 1989. Passive smoking affects endothelium and platelets. Arch. Intern. Med. 149:386–389.
   PubMedGoogle Scholar
• Demers, L. M., Harrison, T. S., Halbert, D. R., and Santen, R. J. 1981. Effect of prolonged exercise on plasma prostaglandin levels. ProstaglandinsMed. 6:413–418.
   Google Scholar
• DeWitt, L., Day, S., Sommenburg, K., and Smith, L. 1983. Concentrations of prostaglandin endoper-oxide synthase and prostaglandin 12 synthase in the endothelium and smooth muscle of bovine aorta.]. Clin. Invest. 72:1882–1888.
   PubMed Web of Science ®Google Scholar
• Dotevall, A., Raangemark, C., Eriksson, E., Kutti, J., Wadenuik, H., and Wennmalm, A. 1992. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. Thromb. Haemostasis 68:583–588.
   PubMed Web of Science ®Google Scholar
• Glantz, S. A., and Parmley, W. W. 1995. Passive smoking and heart disease, mechanisms and risk.]. Am. Med. Assoc. 273(13)1 047–1053.
   Google Scholar
• Haley, N. J., Axelrad, C. M., and Tilton, K. A. 1983. Validation of self-reported smoking behaviour: Biochemical analyses of cotinine and thiocyanate. Am.]. Public Health 73:1204–1207.
   PubMed Web of Science ®Google Scholar
• Hamberg, M., and Samuelsson, B. 1974. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA 71:3400–3404.
   PubMed Web of Science ®Google Scholar
• Hollander, M., and Wolfe, D. A. 1973a. The one-way layout. In Nonparametric statistical methods, eds. R. A. Bradley, J. S. Hunter, D. G. Kendal, and G. S. Watson, pp. 114–137. New York: John Wiley and Sons.
   Google Scholar
• Hollander, M., and Wolfe, D. A. 1973b. The two-sample location problem. In Nonparametric statisti-cal methods, eds. R. A. Bradley, J. S. Hunter, D. G. Kendal, and G. S. Watson, pp. 67–82. New York: John Wiley and Sons.
   Google Scholar
• Kuhn, D. C., Stauffer, J. L., Gaydos, L. J., Lacey, S. L., and Demers, L. M. 1993. An inhibitor of throm-boxane production attenuates tumor necrosis factor release by activated human alveolar macrophages. Prostaglandins 46:196–205.
   Google Scholar
• Langone, J., Gjika, H. B., and Van Vunakis, H. 1973. Nicotine and its metabolites: Radioimmuno-assay for nicotine and cotinine. Biochemistry12:5025–5030.
   PubMed Web of Science ®Google Scholar
• Lassila, R., Seyberth, H. W., Haapanen, A., Schweer, H., Koskenvud, M., and Laustiola, K. E. 1988. Vasoactive and atherogenic effects of cigarette smoking: A study of monozygotic twins discor-dant for smoking. Br. Med.]. 297:955–957.
   PubMedGoogle Scholar
• Mayes, P. A. 1985. Metabolism of lipids: I. Fatty acids. In Harper's review of biochemistry,20th ed., eds. D. W. Martin, P. A. Mayes, V. W. Rodwell, and D. K. Granner, pp. 208–231. Los Altos, CA: Lange.
   Google Scholar
• Milliken, G. A., and Johnson, D. E. 1984. One-way treatment structure in a completely randomized design structure with heterogeneous errors. In Analysis of messy data, vol. I, Designed experi-ments. New York: Van Nostrand Reinhold.
   Google Scholar
• Murray, J. J., Nowak, J., Oates, J. A., and FitzGerald, G. A. 1985. Platelet function during chronic smoking and withdrawal in man. Clin. Res. 33:350A.
   Google Scholar
• Nowak, J., Murray, J. J., Oates, J. A., and FitzGerald, G. A. 1987. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 76:6–14.
   PubMed Web of Science ®Google Scholar
• Ogden, M. W., and Maiolo, K. C. 1992. Comparative evaluation of diffusive and active sampling sys-tems for determining airborne nicotine and 3-ethenylpyridine. Environ. ScL Technol. 26:1226–1234.
   Web of Science ®Google Scholar
• Pernow, J., Hemsén, A., Lundberg, J. M., Nowak, J., and Kaijser, L. 1991. Potent vasoconstrictor effects and clearance of endothelin in the human forearm. Acta PhysioL Scand. 141: 319–324.
   Google Scholar
• Pittilo, R. M., Mackie, I. J., Rowles, P. M., Machin, S. J., and Woolf, N. 1982. Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin. Thromb. Haemostasis 48:173–176.
   Google Scholar
• Rangemark, C., and Wennmalm, A. 1991. Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. Clin. ScL 81:11–15.
   PubMed Web of Science ®Google Scholar
• Siess, W., Lorenz, R., Roth, P., and Weber, P. C. 1982. Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infu-sion. Circulation 66:44–48.
   PubMed Web of Science ®Google Scholar
• Sinzinger, H., and Kefal ides, A. 1982. Passive smoking severely decreases platelet sensitivity to anti-aggregatory prostaglandins. Lancet2:392–393.
   Google Scholar
• Sinzinger, H., and Virgolini, I. 1989. Are passive smokers at greater risk of thrombosis? Wien. Klin. Wochenschr. 101(20):694–698.
   Google Scholar
• Smith, C. J., Sears, S. B., Walker, J. C., and DeLuca, P. 0. 1992. Environmental tobacco smoke: Current assessment and future directions. Toxicol. Pathol. 279:61–73.
   Google Scholar
• Steinberg, D. 1989. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320(14):915–924.
   Google Scholar
• Trap-Jensen, J., Carlsen, J. E., Svendsen, T. L., and Christensen, N. J. 1979. Cardiovascular and adren-ergic effects of cigarette smoking during immediate nonselective and selective beta adreno-receptor blockade in humans. Eur. J. Clin. Invest. 9: 181–183.
   Google Scholar
• Uedelhoven, W. M., Rutzel, A., Meese, C. 0., and Weber, P. C. 1991. Smoking alters thromboxane metabolism in man. Biochim. Biophys. Acta 1081:197–201.
   Google Scholar
• Vial, J. H., Roberts, M. S., McLeod, L. J., and Seville, P. R. 1990. Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin. Aust. N. Z. J. Med. 20:652–656.
   Google Scholar
• Walker, J. C., Jennings, R. A., Morgan, W. T., Robinson, J. H., Griffith, D. W., and Reynolds, J. 1989. Sensory responses to environmental tobacco smoke from cigarettes that heat but do not burn to-bacco. In Present and future of indoor air quality, eds. C. J. Bieva, Y. Courtois, and M. Govaerts, pp. 207–213.. New York: Elsevier.
   Google Scholar
• Wennmalm, A., Benthin, G., Granstroem, E. F., Persson, L., Petersson, A. S., and Winell, S. 1991. Re-lation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metab-olites in young men. Circulation 83:1698–1704.
   PubMed Web of Science ®Google Scholar